Pharmacokinetic (PK) modeling and simulation are fundamental to describe a drug’s fate in a biological system. An understanding of therapeutically effective drug concentrations, dose-related adverse events and…
biological systems presents a complex landscape that demands a comprehensive understanding of drug behavior. Pharmacokinetic modeling has emerged as a pivotal tool in deciphering the dynamic processes that govern drug…
Advancements in pharmacokinetic modeling have revolutionized drug development and clinical practice by providing quantitative insights into drug absorption, distribution, metabolism, and excretion (ADME). This article…
Pharmacokinetics modeling plays a vital role in understanding the behavior of drugs within the human body. It involves studying the processes of drug absorption, distribution, metabolism, and elimination to predict…
Pharmacokinetic modeling is fundamental to drug development, guiding dose optimization and predicting interactions. Modern approaches integrate mechanistic insights with population data, utilize PBPK for ADME…
objective of this study is to develop and validate a population pharmacokinetic model for vancomycin in critically ill patients and investigate the impact of different dosing strategies on achieving therapeutic…
This article explores the application of artificial intelligence (AI) and machine learning (ML) in pharmacokinetic modeling and drug development. Pharmacokinetics, encompassing absorption, distribution, metabolism, and…
integration of artificial intelligence (AI) into pharmacokinetic modeling represents a significant advancement in the field of precision medicine. AI techniques, including machine learning and deep learning, enable the…
minimizing adverse effects, given the unique pharmacokinetic profiles of pediatric patients. Recent advancements in pharmacokinetic modeling and simulation (PKM&S) have significantly improved the accuracy of dosing…
Ensuring Accuracy and Reliability in Drug Development and Clinical Practice. Pharmacokinetic models are indispensable tools for quantifying drug behavior in vivo, crucial for optimizing dosing regimens and predicting…
Physiologically based pharmacokinetic modeling is a mathematical modeling technique for predicting the absorption, distribution, metabolism and excretion of synthetic or natural chemical substances in humans and other…
variability in drug concentrations among individuals within a population. By employing mathematical models, population pharmacokinetics characterizes how drugs are absorbed, distributed, metabolized, and excreted in…
Tmax (2.0 h) values compared to drug suspension.Physiologically based pharmacokinetic (PBPK) model was simulated and verified, then the predicted pharmacokinetic results were compared to the results of the in vivo
compartments such as muscle and fat mass volumes. As of now used patient subordinate pharmacokinetic models don't take under consideration bizarre dissemination come about from heterogeneous sedate conveyance within
This paper studies an appropriate pharmacokinetic (PK) model for hypnosis control based on effect-site anesthetic concentration. For maintaining hypnosis, methods to keep plasma or effect-site concentration of propofol
human body better. Herein, we introduce the concept of combining microfluidics with mathematical modeling that allows us to test the dynamics of multi-organ response to xenobiotic compounds. Termed ... microfluidic…
relatively. Conclusion: Comparing with the general background population as characterized, a systematic population pharmacokinetic (Pop PK) model for Qishe Pill will be established and verified. Ethical research…
diseases. The objectives of this study were to develop a human PBPK model optimized by human pharmacokinetic (PK) data, to predict the PK profiles of YH4808 using the PBPK model ... Comparison of quantum dot…
kinetic modelling of lamotrigine showed that the dr ug exhibited two compartment open model with regard to the goodness of fits, Residual Sum of Squares (RSS), Ak aike’s Information ... time to reach peak plasma…
Dependent Diabetes Mellitus (NIDDM) patients and in healthy subjects by using Physiologically Based Pharmacokinetic (PBPK) modelling with SimCYP simulator. Methodology: A mechanistic Physiologically Based…
create a population pharmacokinetic model for TDM that can be used for Uruguayan patients receiving cyclosporine (CsA) medication. Methods and Patients, There were 53 patients in all who were receiving ... into…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.